06/24/2026
A new study out of UPenn followed 111,000 women and found GLP-1 use was associated with a 30% lower incidence of breast cancer.
This builds on research I've followed for years, showing that sustained weight loss and medications like metformin also lower breast cancer risk in women who are overweight, prediabetic, or diabetic.
This isn't a mandate for every woman to be on a GLP. But if your BMI is elevated, you're prediabetic, or you're diabetic, this is real reinforcement to take it seriously.
Click the link below to learn more and read my thoughts.